The global biologics outsourcing market is expected to grow at a CAGR of around 12.5% over the forecast period. The market growth is attributed to the increasing adoption of advanced technologies for biological production, a rise in outsourcing of R&D activities by pharmaceutical and biopharmaceutical companies and a favorable regulatory environment for clinical trials in developing countries. Further, the increase in the number of mergers and collaborations has increased pharmaceutical and biopharmaceutical outsourcing, with major industry players expanding into developing regions. For instance, in May 2019, Thermo Fisher Scientific, Inc. acquired Brammer Bio, a viral vector contract developer for gene and cell therapies, to strengthen its market position in the area of gene therapy.
Market Segmentation
The global biologics outsourcing market has been analyzed on the basis of product type, source, application, end-use, and region. Based on the product type, the market is segmented into antibodies, recombinant proteins, vaccines, and others. Among these, antibodies segment is estimated to hold a prominent share in the market. Based on source, the market is segmented into human, microbial, and others. The microbial segment is projected to exhibit a considerable growth during the forecast period.
Based on application, the market is segmented into stem cell research, vaccine and therapeutics development, blood & blood-related products development, cellular and gene therapy products development, and others. Stem cell research segment is estimated to hold a prominent share in the market. Based on end-user, the market covers the analysis of therapeutics & diagnostics, and research. Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa.
Market Structure and Competition Landscape
The global biologics outsourcing market is characterized by the presence of significant number of players. Some of the prominent players operating in the market include Lonza Group AG, Wuxi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., Wuxi Biologics (Cayman) Inc., Genescript Biotech Corp., and others. Growing focus on biologics and increasing R&D spending on biologics drugs by these industry players are expected to drive the market. Some of the key developments in the global biologics outsourcing market include:
• In January 2022, Samsung Biologics agreed to pay US$ 2.3 billion for Biogen's 50% stake in Samsung Bioepis, a joint venture between the two companies. This is aimed to improve Samsung Bioepis' biosimilar development capabilities and future performance in new drug development.
• In March 2021, WuXi acquired a single-use biologics production plant in Hangzhou, China, from Pfizer Inc.
Global Biologics Outsourcing Market Analysis and Forecast 2019-2028
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players' expenditures, and economic conditions among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter's Five Forces Analysis
7. Rules & Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Biologics Outsourcing Market: Key Investment Analysis
9.1. By Leading Biologics Companies
9.2. Technological Assessment
9.3. By Region
9.4. M&A Activities
Robust assessment of major investments made by various industry players along with key technological assessment, and key end-use sector
10. Global Biologics Outsourcing Market: Service Cost Analysis
10.1. By Service Type
10.1.1. Antibody Production Service
10.1.2. Custom Monoclonal Antibody Production Service
10.1.3. Custom Polyclonal Antibody Production Service
10.1.4. Protein Production Service
10.1.5. Gene Editing Service
11. Global Biologics Outsourcing Market: Biological Development Phase Analysis
11.1. Discovery
11.2. Pre-Clinical
11.3. Clinical
11.4. Commercialization
12. Parent Market Overview
12.1. Global Life Sciences Market
12.2. Global Healthcare Market
13. Segmental Analysis
13.1. Global Biologics Outsourcing Market by Product Type
13.1.1. Segment Overview
13.1.1.1. Antibodies
13.1.1.1.1. Monoclonal Antibody
13.1.1.1.2. Antibody Drug Conjugates
13.1.1.1.3. Others (Polyclonal Antibodies etc.)
13.1.1.2. Recombinant proteins
13.1.1.3. Vaccines
13.1.1.4. Others (Fusion Proteins, etc.)
13.2. Global Biologics Outsourcing Market by Source
13.2.1. Segment Overview
13.2.1.1. Human
13.2.1.2. Microbial
13.2.1.3. Others (Transgenic Animals such as Avian, Insects, etc.)
13.3. Global Biologics Outsourcing Market by Application
13.3.1. Segment Overview
13.3.1.1. Stem Cell Research
13.3.1.2. Vaccine and Therapeutics Development
13.3.1.3. Blood & Blood-Related Products Development
13.3.1.4. Cellular and Gene Therapy Products Development
13.3.1.5. Others (Tissue & Tissue Related Products Development)
13.4. Global Biologics Outsourcing Market by End Use
13.4.1. Segment Overview
13.4.1.1. Therapeutics and Diagnostics
13.4.1.2. Research
13.5. Global Biologics Outsourcing Market by Region
13.5.1. North America
13.5.2. Latin America
13.5.3. Western Europe
13.5.4. Eastern Europe
13.5.5. Asia Pacific
13.5.6. Middle East & Africa
14. Regional Analysis
14.1. North America Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.1.1. Market Overview
14.1.2. North America Biologics Outsourcing Market by Product Type
14.1.3. North America Biologics Outsourcing Market by Source
14.1.4. North America Biologics Outsourcing Market by Application
14.1.5. North America Biologics Outsourcing Market by End Use
14.1.6. North America Biologics Outsourcing Market by Country
14.1.6.1. US
14.1.6.2. Canada
14.2. Latin America Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.2.1. Market Overview
14.2.2. Latin America Biologics Outsourcing Market by Product Type
14.2.3. Latin America Biologics Outsourcing Market by Source
14.2.4. Latin America Biologics Outsourcing Market by Application
14.2.5. Latin America Biologics Outsourcing Market by End Use
14.2.6. Latin America Biologics Outsourcing Market by Country
14.2.6.1. Brazil
14.2.6.2. Mexico
14.2.6.3. Rest of Latin America
14.3. Western Europe Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.3.1. Market Overview
14.3.2. Western Europe Biologics Outsourcing Market by Product Type
14.3.3. Western Europe Biologics Outsourcing Market by Source
14.3.4. Western Europe Biologics Outsourcing Market by Application
14.3.5. Western Europe Biologics Outsourcing Market by End Use
14.3.6. Western Europe Biologics Outsourcing Market by Country
14.3.6.1. Germany
14.3.6.2. UK
14.3.6.3. France
14.3.6.4. Spain
14.3.6.5. Italy
14.3.6.6. Benelux
14.3.6.7. Nordic
14.3.6.8. Rest of Western Europe
14.4. Eastern Europe Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.4.1. Market Overview
14.4.2. Eastern Europe Biologics Outsourcing Market by Product Type
14.4.3. Eastern Europe Biologics Outsourcing Market by Source
14.4.4. Eastern Europe Biologics Outsourcing Market by Application
14.4.5. Eastern Europe Biologics Outsourcing Market by End Use
14.4.6. Eastern Europe Biologics Outsourcing Market by Country
14.4.6.1. Russia
14.4.6.2. Poland
14.4.6.3. Rest of Eastern Europe
14.5. Asia Pacific Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.5.1. Market Overview
14.5.2. Asia Pacific Biologics Outsourcing Market by Product Type
14.5.3. Asia Pacific Biologics Outsourcing Market by Source
14.5.4. Asia Pacific Biologics Outsourcing Market by Application
14.5.5. Asia Pacific Biologics Outsourcing Market by End Use
14.5.6. Asia Pacific Biologics Outsourcing Market by Country
14.5.6.1. China
14.5.6.2. Japan
14.5.6.3. India
14.5.6.4. South Korea
14.5.6.5. Australia
14.5.6.6. ASEAN
14.5.6.7. Rest of Asia-Pacific
14.6. Middle East & Africa Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.6.1. Market Overview
14.6.2. Middle East & Africa Biologics Outsourcing Market by Product Type
14.6.3. Middle East & Africa Biologics Outsourcing Market by Source
14.6.4. Middle East & Africa Biologics Outsourcing Market by Application
14.6.5. Middle East & Africa Biologics Outsourcing Market by End Use
14.6.6. Middle East & Africa Biologics Outsourcing Market by Country
14.6.6.1. GCC
14.6.6.2. South Africa
14.6.6.3. Turkey
14.6.6.4. Rest of the Middle East & Africa
15. Competitive Landscape
15.1. Competition Dashboard
15.1.1. Global and Regional Market Share Analysis
15.1.2. Market Structure
15.2. Competitive Benchmarking
15.3. Key Strategy Analysis
15.4. Company Profiles
15.4.1. Lonza Group AG
15.4.1.1. Company Overview
15.4.1.2. Product/Service Offerings
15.4.1.3. Key Financials
15.4.1.4. Recent Developments
15.4.2. Wuxi Biologics (Cayman) Inc.
15.4.2.1. Company Overview
15.4.2.2. Product/Service Offerings
15.4.2.3. Financials
15.4.2.4. Recent Developments
15.4.3. Boehringer Ingelheim International GmbH
15.4.3.1. Company Overview
15.4.3.2. Product/Service Offerings
15.4.3.3. Financials
15.4.3.4. Recent Developments
15.4.4. Abzena Ltd.
15.4.4.1. Company Overview
15.4.4.2. Product/Service Offerings
15.4.4.3. Financials
15.4.4.4. Recent Developments
15.4.5. GL Biochem Corp.
15.4.5.1. Company Overview
15.4.5.2. Product/Service Offerings
15.4.5.3. Financials
15.4.5.4. Recent Developments
15.4.6. Catalent, Inc.
15.4.6.1. Company Overview
15.4.6.2. Product/Service Offerings
15.4.6.3. Financials
15.4.6.4. Recent Developments
15.4.7. Samsung Biologics Co.Ltd.
15.4.7.1. Company Overview
15.4.7.2. Product/Service Offerings
15.4.7.3. Financials
15.4.7.4. Recent Developments
15.4.8. ThermoFisher Scientific Inc.
15.4.8.1. Company Overview
15.4.8.2. Product/Service Offerings
15.4.8.3. Financials
15.4.8.4. Recent Developments
15.4.9. Syngene International Ltd.
15.4.9.1. Company Overview
15.4.9.2. Product/Service Offerings
15.4.9.3. Financials
15.4.9.4. Recent Developments
15.4.10. Rentschler Biopharma SE
15.4.10.1. Company Overview
15.4.10.2. Product/Service Offerings
15.4.10.3. Financials
15.4.10.4. Recent Developments
15.4.11. Abbvie Inc.
15.4.11.1. Company Overview
15.4.11.2. Product/Service Offerings
15.4.11.3. Financials
15.4.11.4. Recent Developments
15.4.12. Genscript Biotech Corp.
15.4.12.1. Company Overview
15.4.12.2. Product/Service Offerings
15.4.12.3. Financials
15.4.12.4. Recent Developments
*List of companies is not exhaustive
16. Disclaimer
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Services |
Pages : 200 |
Request Sample 
Request Discount 
Inquire Before Buy
